Get startedLog in
    Picture of OptimizeRx logo

    OPRX — OptimizeRx Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    TechnologyAdventurousSmall CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for OptimizeRx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-2.210.378-11.4-17.6-20.1
    Depreciation
    Non-Cash Items3.625.6916.123.519.7
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-9.69-7.313.96-15.50.921
    Change in Accounts Receivable
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Cash from Operating Activities-6.310.72610.7-7.244.89
    Capital Expenditures-0.125-0.464-0.243-0.871-0.45
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Software Development Costs
    Other Investing Cash Flow Items0-0.022-57.9-24.5—
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Change in Net Intangibles
    Cash from Investing Activities-0.125-0.486-58.2-25.3-0.45
    Financing Cash Flow Items-4.39-1.610—-0.911
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-1.973.9-1928.2-4.91
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-8.3474.2-66.5-4.36-0.472